Uso de corticoides e anti-histamínicos na prevenção da anafilaxia: uma revisão bibliométrica
Use of corticosteroids and antihistamines in the prevention of anaphylaxis: a bibliometric review
Maria Cecília Barata dos Santos Figueira; Emanuel Sávio Cavalcanti Sarinho
Resumo
Apesar de pouca evidência, é comum a prescrição de corticoides e anti-histamínicos como preventivos de anafilaxia. O objetivo deste estudo foi realizar uma análise bibliométrica sobre o uso de esteroides e anti-histamínicos como medicamentos preventivos de anafilaxia. Para tanto, foi realizada busca ativa de artigos publicados até outubro de 2016 na base de dados Scopus contendo os termos “anaphylaxis and prevention and steroid or antihistaminic” nos campos título, resumo e palavra-chave. Realizada a leitura dos artigos selecionados, na íntegra, com busca específica do foco do estudo, que foi sobre o uso de corticoide e/ou anti-histamínico na prevenção da anafilaxia. Foram encontrados 292 artigos publicados até outubro 2016 na base de dados Scopus. Ao realizar busca dos 104 artigos completos elegíveis, foram incluídos no estudo apenas 49 artigos pela referência explícita aos medicamentos do foco de estudo como possíveis preventivos, e por serem estudos mais recentes, com disponibilidade e digitalização existentes. Nenhum dos 49 artigos lidos na íntegra abordou especificamente o papel dos corticoides e/ou anti-histamínicos na prevenção da anafilaxia. No momento, não há na literatura evidência de que o uso de corticoides e anti-histamínicos seja benéfico ou traga malefício na prevenção da anafilaxia.
Palavras-chave
Abstract
Despite the scarcity of evidence, prescribing corticosteroids and antihistamines to prevent anaphylaxis is a common practice. The objective of this study was to perform a bibliometric analysis of the use of these drugs for anaphylaxis prevention. In the present study, articles published until October 2016 were actively searched in the Scopus database using the terms “anaphylaxis and prevention and steroid or antihistaminic” in the title, abstract, and keyword fields. Selected articles were fully read and searched for the specific variable under investigation, i.e., the use of the corticosteroid and/or antihistamine to prevent anaphylaxis. A total of 292 articles published until October 2016 were initially identified in the Scopus database. When searching for the 104 full-length eligible articles, only 49 made clear reference to the use of the drugs to potentially prevent anaphylaxis and were digitally available. None of the 49 articles fully read addressed specifically the role of corticosteroids and/or antihistamines in preventing anaphylaxis. At present, there is no evidence in the literature that the use of corticosteroids and antihistamines is either beneficial or detrimental to the prevention of anaphylaxis.
Keywords
Referências
1. Sampson HA, Muñoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, et al. Symposium on the Definition and Management of Anaphylaxis: Summary report. J Allergy Clin Immunolournal Allergy Clin Immunol. 2005;115(3):584‑91.
2. Panesar SS, Javad S, De Silva D, Nwaru BI, Hickstein L, Muraro A, et al. The epidemiology of anaphylaxis in Europe: A systematic review. Allergy Eur J Allergy Clin Immunol. 2013;68:1353‑61.
3. Rudders SA, Arias SA, Camargo Junior CA. Trends in hospitalizations for food-induced anaphylaxis in US children, 2000-2009. J Allergy Clin Immunol. 2014;134(4):960‑2.
4. Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: An analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol. 2015;135:956‑63.
5. Bernd L a G, Fleig F, Alves MB, Di Gesu GMS, Di Gesu RW, Mario Geller, et al. Anafilaxia no Brasil – Levantamento da ASBAI. Rev bras alerg imunopatol. 2010;33(5):190‑8.
6. Lieberman P, Nicklas RA, Randolph C, Oppenheimer J, Bernstein D, Bernstein J, et al. Anaphylaxis – a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115:341‑84.
7. Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM. The diagnosis and management of anaphylaxis practice parameter: 2010 Update. J Allergy Clin Immunol. 2010;126(3):477‑80.
8. Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez Rivas M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. 2014;69(8):1026‑45.
9. Simons FER, Ebisawa M, Sanchez-borges M, Thong BY, Worm M, Tanno LK, et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J. 2015;1‑16.
10. Campbell RL, Li JTC, Nicklas RA, Sadosty AT. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy, Asthma Immunol. 2014;113(6):599‑608.
11. Simons FER, Ardusso LRF, Bilò MB. World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis. World Allergy Organ J. 2011;13‑37.
12. Brunton LL, Chabner AB, Knollmann BC. In: Goodman L, Gilman A. As Bases Farmacológicas da Terapêutica. 12ª ed. Mc Graw Hill/ Artmed; 2012. p.277-333, p.911-35, p.1209-36.
13. Choo KJL, Simons E, Sheikh A. Glucocorticoids for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2010;65:1205‑11.
14. Sheikh A, Broek V, Brown SGA, Simons FER. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2007;62:830‑7.
15. Dhami S, Panesar SS, Roberts G, Muraro A, Worm M, Bilò MB, et al. Management of anaphylaxis: A systematic review. Allergy Eur J Allergy Clin Immunol. 2014;69(2):168‑75.
16. Simons FER, Ardusso LR, Bilò MB, Cardona V, Ebisawa M, ElGamal YM, et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J. 2014;7(9):1‑19.
17. Simons FER, Ardusso LRF, Dimov V, Ebisawa M, El-Gamal YM, Lockey RF, et al. World allergy organization anaphylaxis guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol. 2013;162:193‑204.
18. Simons FER, Ardusso LRF, Bilo MB, Dimov V, Ebisawa M, El-gamal YM, et al. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol. 2012;12(4):389‑99.
19. Bernd LAG, Sá AB De, Watanabe AS, Castro APM, Solé D, Castro FM, et al. Practical guide to the management of anaphylaxis - 2012. Rev bras alerg imunopatol. 2012;35(2):53‑70.
20. McKinnon RP. Allergic reactions during anaesthesia. Curr Opin Anaesthesiol. 1996;9:267‑70.
21. Ebo DG, Stevens WJ. IgE-mediated food allergy – extensive review of the literature. Acta Clin Belg. 2001;56(4):234‑47.
22. Dickinson MC, Kam PCA. Intravascular iodinated contrast media and the anaesthetist. Anaesthesia. 2008;63:626‑34.
23. Goss JE, Chambers CE, Heupler Jr. FA, Cumpston N. Systemic anaphylactoid reactions to iodinated contrast media during cardiac catheterization procedures: guidelines for prevention, diagnosis, and treatment. Cathet Cardiovasc Diagn. 1995;34:99‑104.
24. Sreevastava DK, Tarneja VK. Anaphylactic reaction: an overview. Med J Armed Forces India. 2003;59(1):53‑6.
25. Kobrynski LJ. Anaphylaxis. Clin Pediatr Emerg Med. 2007;8:110‑6.
26. Liccardi G, Lobefalo G, Di Florio E, Di Iorio C, Occhiochiuso L, Romano L, et al. Strategies for the prevention of asthmatic, anaphylactic and anaphylactoid reactions during the administration of anesthetics and/or contrast media. J Investig Allergol Clin Immunol. 2008;18(1):1‑11.
27. Joerger M. Prevention and handling of acute allergic and infusion reactions in oncology. Ann Oncol. 2012;23(SUPPL. 10):x313–9.
28. Moore LE, Kemp AM, Kemp SF. Recognition, treatment, and prevention of anaphylaxis. Immunol Allergy Clin North Am. 2015;35:363‑74.
29. Morcos SK. Life threatening and fatal contrast media reactions: pathomechanisms, diagnosis, prevention and drug management. Antiinflamm Antiallergy Agents Med Chem. 2006;5:119‑28.
30. Peters GA, Hodgson JR DR. The effect of premedication with chlorpheniramine on reactions to methylglucamine iodipamide. J Allergy. 1966;38(2):74‑83.
31. Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Muller U. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy [Internet]. 2005;60(12):1459‑70.
32. Moss J. Use of prophylactic combined H1 and H2 antagonists reduces mortality in chymopapain anaphylaxis. Ann Fr Anesth Reanim. 1985;4:221‑4.
33. Kambam J, Meszaros R, Merrill W, Stewart J, Smith BE, Bender H. Prophylactic administration of histamine1 and histamine 2 receptor blockers in the prevention of protamine-related haemodynamic effects. Can J Anaesth. 1990;37(4):420‑2.
34. Brockow K, Kiehn M, Riethmüller C, Vieluf D, Berger J, Ring J. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol. 1997;100(4):458‑63.
35. Miller WL, Doppman JL, Kaplan AP. Renal arteriography following systemic reaction to contrast material. J Allergy Clin Immunol. 1975;56(4):291‑5.
36. Lieberman P. Anaphylactic reactions during surgical and medical procedures. J Allergy Clin Immunol. 2002;110(2):64‑9.
37. Fisher MM, Doig GS. Prevention of anaphylactic reactions to anaesthetic drugs. Drug Saf. 2004;27(6):393‑410.
38. Delaney A, Carter A, Fisher M. The prevention of anaphylactoid reactions to iodinated radiological contrast media: a systematic review. BMC Med Imaging. 2006;6(2):1‑7.
39. Tramèr MR, von Elm E, Loubeyre P, Hauser C. Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review. BMJ. 2006;333:1‑6.
40. Martorell A, Alonso E, Boné J, Echeverría L, López MC, Martín F, et al. Position document: IgE-mediated allergy to egg protein. Allergol Immunopathol (Madr). 2013;41(5):320‑36.
41. Bennett JR. Anaphylaxis attributed to exercise: considerations for sports medicine specialists. Phys Sport. 2015;43(1):1‑12.
42. Gomez AVM, Belver MTB, Alvarez NC, Muñoz MTG, Sastre VH. Perioperative anaphylactic reactions: Review and procedure protocol in paediatrics. Allergol Immunopathol (Madr). 2015;43(2):203‑14.
43. Lee S, Sadosty AT, Campbell RL. Update on biphasic anaphylaxis. Curr Opin Allergy Clin Immunol. 2016 Aug;16(4):346-51.
44. Liebhart J, Panaszek B. Drug-induced shock. Pharmacol Rep. 2007;59(suppl. 1):99‑103.
45. Silva HA, Pathmeswaran A, Ranasinha CD, Jayamanne S, Samarakoon SB, Hittharage A, et al. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, doubleblind, placebo-controlled trial. PLoS Med. 2011;8(5):1‑10.
46. Habib AG. Effect of pre-medication on early adverse reactions following antivenom use in snakebite – a systematic review and meta-analysis. Drug Saf. 2011;34(10):869‑80.
47. Muller UR, Jutel M, Reimers A, Zumkehr J, Tec S, Huber C. Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy. J Allergy Clin Immunol. 2008;122(5):1001‑7.
48. Bilo MB. Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment. Allergy. 2011;66(95):35‑7.
49. Schulze J, Rose M, Zielen S. Beekeepers anaphylaxis: sucessful immunotherapy covered by omalizumab. Allergy. 2007;62:963‑4.
Submetido em:
15/08/2017
Aceito em:
02/10/2017
Facebook
LinkedIn
Mendeley
StumbleUpon
Reddit
Email